Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak
Katherine J. Siddle, Lydia A. Krasilnikova, Gage K. Moreno, et al.
Cell (2021) Vol. 185, Iss. 3, pp. 485-492.e10
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Covid-19 Vaccines — Immunity, Variants, Boosters
Dan H. Barouch
New England Journal of Medicine (2022) Vol. 387, Iss. 11, pp. 1011-1020
Open Access | Times Cited: 378
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Jinyi Tang, Cong Zeng, Thomas M Cox, et al.
Science Immunology (2022) Vol. 7, Iss. 76
Open Access | Times Cited: 262
Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
Na Fan, Kepan Chen, Rong Zhu, et al.
Science Advances (2022) Vol. 8, Iss. 51
Open Access | Times Cited: 54
Vaccination with S pan , an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice
Yongliang Zhao, Wenjia Ni, Simeng Liang, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 677
Open Access | Times Cited: 24
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective
Jasmine R Marcelin, Audrey Pettifor, Holly Janes, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 33
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 30
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Stuart G. Tangye, Laurent Abel, Salah Al-Muhsen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 818-831
Open Access | Times Cited: 29
Multimodal surveillance of SARS-CoV-2 at a university enables development of a robust outbreak response framework
Brittany A. Petros, Jillian S. Paull, Christopher H. Tomkins-Tinch, et al.
Med (2022) Vol. 3, Iss. 12, pp. 883-900.e13
Open Access | Times Cited: 28
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
Michael S. Seaman, Mark J. Siedner, Julie Boucau, et al.
JCI Insight (2022) Vol. 7, Iss. 19
Open Access | Times Cited: 25
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
Michael S. Seaman, Mark J. Siedner, Julie Boucau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
Sapna Sharma, Thomas Vercruysse, Lorena Sanchez‐Felipe, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants
Charles B. Stauft, Prabhuanand Selvaraj, Felice D’Agnillo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice
Bhawana Pandey, Zhengying Wang, Angela Jimenez, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
SARS-CoV-2 Genomic Diversity in Households Highlights the Challenges of Sequence-Based Transmission Inference
Emily E. Bendall, Gabriela Paz‐Bailey, Gilberto A. Santiago, et al.
mSphere (2022) Vol. 7, Iss. 6
Open Access | Times Cited: 12
Public Health Needs the Public Trust: A Pandemic Retrospective
Matthew Halma, Joshua Guetzkow
BioMed (2023) Vol. 3, Iss. 2, pp. 256-271
Open Access | Times Cited: 7
A Novel Rolling Circle Amplification-Based Detection of SARS-CoV-2 with Multi-Region Padlock Hybridization
Rajesh Kumari, Ji Won Lim, Matthew Sullivan, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2252-2252
Open Access | Times Cited: 10
Signatures of transmission in within-host Mycobacterium tuberculosis complex variation: a retrospective genomic epidemiology study
Katharine S. Walter, Ted Cohen, Barun Mathema, et al.
The Lancet Microbe (2024), pp. 100936-100936
Open Access | Times Cited: 1
Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?
Harald Brüssow
Microbial Biotechnology (2022) Vol. 16, Iss. 1, pp. 3-14
Open Access | Times Cited: 8
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2
Marlena S. Bannick, Fei Gao, Elizabeth R. Brown, et al.
American Journal of Epidemiology (2023) Vol. 192, Iss. 6, pp. 1016-1028
Open Access | Times Cited: 4
Comparison of initial clinic characteristics of hospitalized patients in Suzhou City during the COVID-19 Omicron wave with ancestral variant wave
Binbin Gu, Yao Lin, Xin-yun Zhu, et al.
Therapeutic Advances in Respiratory Disease (2022) Vol. 16
Open Access | Times Cited: 6
Challenges in Harnessing Shared Within-Host Severe Acute Respiratory Syndrome Coronavirus 2 Variation for Transmission Inference
Katharine S. Walter, Eugene Kim, Renu Verma, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 3
Transmission of SARS-CoV-2 Omicron Variant under a Dynamic Clearance Strategy in Shandong, China
Yifei Xu, Ti Liu, Yan Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 3
Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19
Renuka Roche, Nouha Odeh, Abhay Andar, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1963-1963
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top